Compare Microsoft (MSFT) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Microsoft vs NeoGenomics Inc. Common Stock — how do they compare? Microsoft trades at $531.93 (market cap $3.96T), while NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B). The key difference: Microsoft is far larger — about 1824.9× NeoGenomics Inc. Common Stock's market cap, and Microsoft pays a 0.73% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Microsoft for 142 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| MSFT | NEO | |
|---|---|---|
Market Cap | $3.96T | $2.17B |
Volume | 22,251,503 | 1,615,943 |
Sector | Technology | Health |
52-Week High | $543.45 | $19.91 |
52-Week Low | $352.83 | $7.19 |
Typical Hold Time | 142 Days | 0 Days |
Enterprise Value | $3.94T | $2.47B |
Dividend Yield | 0.73% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Microsoft (MSFT) trades at $543.45, up 0.43% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with Q2 2026 EPS of $4.74 beating estimates of $4.24, continuing a trend of earnings outperformance. Revenue growth accelerated to $281.72B in 2025 with impressive 40.31% net income margin. Analyst consensus remains overwhelmingly positive with 82% buy ratings and $577.52 price target representing 6.3% upside potential.
Microsoft's AI leadership and cloud dominance position it for sustained growth, though elevated P/E of 30.28 and RSI levels near 83 suggest potential near-term consolidation. Key risks include increased capital expenditure pressures and competitive threats in AI infrastructure. The stock offers strong long-term prospects but may face volatility from valuation concerns and macroeconomic headwinds affecting tech sector performance.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Microsoft
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
